Lanean...
Hepatitis C virus vaccine design: focus on the humoral immune response
Despite the recent development of safe and highly effective direct-acting antivirals, hepatitis C virus (HCV) infection remains a significant health problem. In 2016, the World Health Organization set out to reduce the rate of new HCV infections by 90% by 2030. Still, global control of the virus doe...
Gorde:
| Argitaratua izan da: | J Biomed Sci |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7338099/ https://ncbi.nlm.nih.gov/pubmed/32631318 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-020-00669-4 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|